发明名称 |
Methods of inhibiting atrophy or promoting hypertrophy |
摘要 |
A method of inhibiting skeletal muscle atrophy or increasing skeletal muscle hypertrophy in muscle cells in a vertebrate animal, by inhibiting signaling pathways that lead to skeletal muscle atrophy and activating pathways that lead to skeletal hypertrophy. In particular, by treating the cells with a specific activator of the PI3K/Akt pathway. Also provided is a method of identifying a test agent that inhibits atrophy or causes hypertrophy in muscle cells. This method comprises: (a) obtaining cells that express the following: 1) Akt; 2) an Akt substrate/reporter construct capable of measuring Akt substrate activation; 3) Raf; 4) a Raf substrate/reporter construct capable of measuring Raf substrate activation; (b) subjecting the cells to a test agent; (c) measuring the amount of Akt substrate activation in (a) (2); (d) measuring the amount of Raf substrate activation in (a) (4), wherein activation of the Akt substrate absent activation of the Raf substrate is used to identify a test agent that inhibits muscle atrophy.
|
申请公布号 |
NZ519087(A) |
申请公布日期 |
2004.11.26 |
申请号 |
NZ20000519087 |
申请日期 |
2000.11.17 |
申请人 |
REGENERON PHARMACEUTICALS, INC |
发明人 |
GLASS, DAVID J;ROMMEL, CHRISTIAN;BODINE, SUE C;YANCOPOULOS, GEORGE D |
分类号 |
C12N15/09;A61K38/00;A61K38/30;A61K45/00;A61P21/00;A61P21/02;A61P43/00;C12N5/10;C12Q1/02;G01N33/50;(IPC1-7):A61K38/00;A61P3/02;A61P3/10;A61P25/00;A61K31/00;G01N33/58;G01N33/68 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|